These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 789414)

  • 81. Vasopressin analogue DDAVP in diabetes insipidus: clinical and laboratory studies.
    Edwards CR; Kitau MJ; Chard T; Besser GM
    Br Med J; 1973 Aug; 3(5876):375-8. PubMed ID: 4581079
    [TBL] [Abstract][Full Text] [Related]  

  • 82. Prolonged antidiuresis by 1-desamino-8-D-arginine vasopressin (DDAVP): correlation to its plasma levels and nephrogenous cyclic AMP production.
    Katayama S; Itabashi A; Yamaji T
    Endocrinol Jpn; 1980 Jun; 27(3):363-70. PubMed ID: 6254752
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Management of cranial diabetes insipidus with oral desmopressin (DDAVP).
    Cunnah D; Ross G; Besser GM
    Clin Endocrinol (Oxf); 1986 Mar; 24(3):253-7. PubMed ID: 3708875
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Effects of lysine-vasopressin and 1-deamino-8-D-arginine-vasopressin on memory in healthy individuals and diabetes insipidus patients.
    Laczi F; Valkusz Z; Lászlo FA; Wagner A; Járdánházy T; Szász A; Szilárd J; Telegdy G
    Psychoneuroendocrinology; 1982; 7(2-3):185-93. PubMed ID: 7178372
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Diabetes insipidus: a physiologic approach to diagnosis.
    Oliver RE; Jamison RL
    Postgrad Med; 1980 Dec; 68(6):120-31. PubMed ID: 7433311
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Synthesis and some pharmacological properties of deamino(4-threonine,8-D-arginine)vasopressin and deamino(8-D-arginine)vasopressin, highly potent and specific antidiuretic peptides, and (8-D-arginine)vasopressin and deamino-arginine-vasopressin.
    Manning M; Balaspiri L; Moehring J; Haldar J; Sawyer WH
    J Med Chem; 1976 Jun; 19(6):842-5. PubMed ID: 950656
    [TBL] [Abstract][Full Text] [Related]  

  • 87. Urinary adenosine 3',5'-monophosphate (cAMP) response to antidiuretic hormone in diabetes insipidus (DI): comparison between congenital nephrogenic DI type 1 and 2, and vasopressin sensitive DI.
    Ohzeki T
    Acta Endocrinol (Copenh); 1985 Apr; 108(4):485-90. PubMed ID: 2986401
    [TBL] [Abstract][Full Text] [Related]  

  • 88. DI patient refractory to vasopressin and dDAVP: absence of antibodies to AVP and dDAVP and inactivating factor in blood serum.
    Slaninová J; Skopková J; Barth T; Lichardus B; Földes O
    Int J Clin Pharmacol Biopharm; 1979 Feb; 17(2):84-6. PubMed ID: 570558
    [TBL] [Abstract][Full Text] [Related]  

  • 89. DDAVP in treatment of vasopressin-sensitive diabetes insipidus.
    Ward MK; Fraser TR
    Br Med J; 1974 Jul; 3(5923):86-9. PubMed ID: 4851464
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Pharmacokinetics of 1-deamino-8-D-arginine vasopressin after various routes of administration in healthy volunteers.
    Fjellestad-Paulsen A; Höglund P; Lundin S; Paulsen O
    Clin Endocrinol (Oxf); 1993 Feb; 38(2):177-82. PubMed ID: 8435898
    [TBL] [Abstract][Full Text] [Related]  

  • 91. The abnormal quinine drinking aversion in the Brattleboro rat with diabetes insipidus is reversed by the vasopressin agonist DDAVP: a possible role for vasopressin in the motivation to drink.
    Laycock JF; Chatterji U; Seckl JR; Gartside IB
    Physiol Behav; 1994 Mar; 55(3):407-12. PubMed ID: 8190753
    [TBL] [Abstract][Full Text] [Related]  

  • 92. Differing responses of cortisol to oCRF during endonasal and oral treatment with DDAVP.
    Carraro A; Giusti M; Porcella E; Sessarego P; Giordano G
    Eur J Clin Invest; 1994 Jul; 24(7):459-62. PubMed ID: 7957502
    [TBL] [Abstract][Full Text] [Related]  

  • 93. The effect of DDAVP on intravenous urography.
    Dixon AK; Webb JA; Cattell WR; Fry IK
    Br J Radiol; 1981 Jun; 54(642):484-7. PubMed ID: 7237025
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Oral desmopressin in central diabetes insipidus.
    Westgren U; Wittström C; Harris AS
    Arch Dis Child; 1986 Mar; 61(3):247-50. PubMed ID: 3963868
    [TBL] [Abstract][Full Text] [Related]  

  • 95. [Long-term experience with 1-deamino-8-D-arginin vasopressin (DDAVP) treatment of children with diabetes insipidus centralis (author's transl)].
    Némethová V; Lichardus B; Lehotská V
    Bratisl Lek Listy; 1979 Feb; 71(2):217-24. PubMed ID: 427617
    [No Abstract]   [Full Text] [Related]  

  • 96. Management of early postoperative diabetes insipidus with parenteral desmopressin.
    Chanson P; Jedynak CP; Czernichow P
    Acta Endocrinol (Copenh); 1988 Apr; 117(4):513-6. PubMed ID: 3291526
    [TBL] [Abstract][Full Text] [Related]  

  • 97. [Treatment of post-neurosurgical diabetes insipidus with desmopressin by intramuscular route].
    Jedynak CP; Chanson P; Czernichow P; Loirat P; Derome P
    Presse Med; 1988 Apr; 17(15):723-6. PubMed ID: 2968549
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Clinical experience with desmopressin: efficacy and safety in central diabetes insipidus and other conditions.
    Harris AS
    J Pediatr; 1989 Apr; 114(4 Pt 2):711-8. PubMed ID: 2647953
    [TBL] [Abstract][Full Text] [Related]  

  • 99. Inhibition of the diuretic action of glibenclamide by clofibrate, carbamazepine and 1-deamino-8-d-arginine-vasopressin (DDAVP) in patients with pituitary diabetes insipidus.
    Radó JP; Szende L; Marosi J; Juhos E; Sawinsky I; Takó J
    Acta Diabetol Lat; 1974; 11(3):179-97. PubMed ID: 4218049
    [No Abstract]   [Full Text] [Related]  

  • 100. Treatment of diabetes insipidus in children with DDAVP, a synthetic analogue of vasopressin.
    Aronson AS; Andersson KE; Bergstrand CG; Mulder JL
    Acta Paediatr Scand; 1973 Mar; 62(2):133-40. PubMed ID: 4691456
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.